Immunohistochemistry staining (IHS) showed that the expressions of GRK2 and GRK3 were significantly lower in tumor than in adjacent tissues, correlated with disease-free survival and overall survival (OS) in HCC patients [16, 17], while the GRK6 might mediate a tumor growth signaling [18]. This evidence concerns the gene GRK6 and hepatocellular carcinoma.